Cannibalism: A Biological and Evolutionary Perspective
Sounds of Science Podcast
Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
- Rudolf-Schulten-Strasse 5
- Julich , 52428
Since its founding in 1991, DASGIP AG has established itself as a global provider of technologically-superior parallel bioreactor systems. Today, DASGIP boasts nine of the world's ten largest pharmaceutical companies as customers.